Objectives: To improve the differentiation of borderline ovarian-adnexal tumours (BOTs) from malignant ovarian-adnexal masses, most of which fall into the indeterminate O-RADS MRI 4 category, by developing a multimodal predictive model that integrates clinical, analytic, and MRI parameters. Methods: This retrospective, single-centre study included 248 women who underwent standardised MRI for ovarian-adnexal mass characterisation between 2019 and 2024. Of these, 201 had true ovarian-adnexal masses (114 benign, 22 borderline, and 65 malignant), confirmed by histopathology or stability after ≥12-month follow-up. Forty-one clinical, laboratory, and imaging variables were initially assessed, and after a bivariate evaluation, 18 final predictors with clinical relevance were selected for model construction with thresholds learned from the data. A classification and regression tree (CART) model (“Full Model”) was applied as a second-stage tool after O-RADS MRI scoring, using 10-fold cross-validation to prevent overfitting. A pruned “Simplified Model” was also derived to enhance interpretability. Results: O-RADS MRI performed well at the extremes (scores 2–3 and 5) but showed limited discrimination between BOTs and malignancies within category 4 (PPV for borderline = 0.50). The decision-tree models significantly improved diagnostic performance, increasing overall accuracy from 0.856 with O-RADS MRI alone to 0.905 (Simplified Model) and 0.955 (Full Model). The PPV for BOTs within the intermediate O-RADS MRI 4 category increased from 0.49 with O-RADS MRI alone to 0.77 and 0.90 with the simplified and full models, respectively, while maintaining high accuracy for benign and malignant lesions. Conclusions: In this retrospective single-centre cohort, the addition of an interpretable rule-based predictive model as a second-line tool within O-RADS MRI category 4 was associated with improved discrimination between borderline and invasive malignant ovarian-adnexal tumours. These findings suggest that multimodal integration of clinical, laboratory, and MRI features may help refine risk stratification in indeterminate cases; however, external validation in prospective multicentre cohorts is required before clinical implementation.
Background/Objectives: Although ultrasound-guided fine-needle aspiration biopsy with suction (FNA-S) is preferred for evaluating thyroid nodules, the capillary technique (FNA-C) is also used. However, the diagnostic performance of both techniques remains unclear. Our objective was to compare the diagnostic performance of FNA-S versus FNA-C for thyroid nodules. Methods: This retrospective, observational, exploratory, single-center pilot evaluation study was conducted at a tertiary hospital from January 2023 to June 2024. A total of 157 ultrasound-guided FNA biopsies were prospectively analyzed, comprising 71 FNA-S and 86 FNA-C procedures. Clinical, ultrasound, and cytological parameters were evaluated to compare the rates of non-diagnostic samples (Bethesda I) and the necessity for repeat punctures. Bivariate analyses and multivariate logistic regression were conducted. Results: Both techniques exhibited comparable rates of non-diagnostic samples (28.17% for FNA-S and 27.91% for FNA-C; p = 0.220) and repetition rates (38.03% for FNA-S and 43.02% for FNA-C; p = 0.637). The only factors significantly associated with sample adequacy, regardless of techniques employed, were the location and composition of the nodule. Conclusions: Ultrasound-guided FNA-S and FNA-C yield similar diagnostic performance for biopsy of thyroid nodules. The choice may depend on operator preference and nodule characteristics.